2022-08-16 | OptimizeRx Corporation OPRX | CCO | 3,200 0.0176% | $15.66 | $50,112 | -4.87% | ||
2021-12-17 | Sale | OptimizeRx Corporation OPRX | CHIEF COMMERCIAL OFFICER | 13,241 0.0738% | $54.87 | $726,534 | -53.16% | |
2021-11-17 | Sale | OptimizeRx Corporation OPRX | CHIEF COMMERCIAL OFFICER | 13,241 0.0758% | $73.98 | $979,569 | -61.21% | |
2021-10-18 | Sale | OptimizeRx Corporation OPRX | CHIEF COMMERCIAL OFFICER | 13,241 0.0735% | $85.38 | $1.13M | -58.19% | |
2021-09-17 | Sale | OptimizeRx Corporation OPRX | CCO | 13,242 0.0733% | $69.79 | $924,159 | -43.97% | |
2021-08-17 | Sale | OptimizeRx Corporation OPRX | CHIEF COMMERCIAL OFFICER | 13,242 0.0743% | $58.41 | $773,465 | -27.24% | |
2021-07-20 | Sale | OptimizeRx Corporation OPRX | CHIEF COMMERCIAL OFFICER | 13,242 0.0727% | $50.34 | $666,602 | -6.08% | |
2021-06-17 | Sale | OptimizeRx Corporation OPRX | CHIEF COMMERCIAL OFFICER | 13,242 0.076% | $53.44 | $707,652 | +1.71% | |
2021-05-17 | Sale | OptimizeRx Corporation OPRX | CHIEF COMMERCIAL OFFICER | 26,484 0.0877% | $25.11 | $665,146 | +24.85% |